发明名称 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors
摘要 The present invention provides pyrrolo[2,3-b]pyridine-4-yl amines pyrrolo[2,3-b]pyrimidin-4-yl amines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases and cancer.
申请公布号 US9580419(B2) 申请公布日期 2017.02.28
申请号 US201514799777 申请日期 2015.07.15
申请人 Incyte Corporation;Incyte Holdings Corporation 发明人 Rodgers James D.;Wang Haisheng;Combs Andrew P.;Sparks Richard B.
分类号 C07D401/02;C07D401/10;A61K31/437;C07D471/04;C07D487/04 主分类号 C07D401/02
代理机构 Fish & Richardson P.C. 代理人 Fish & Richardson P.C.
主权项 1. A method of treating dermatitis in a patient, comprising topically administering to said patient a therapeutically effective amount of a compound which is 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-piperidin-1-yl}-3-oxo-propionitrile, or a pharmaceutically acceptable salt thereof.
地址 Wilmington DE US